Risk Factor Control Before Orthopedic Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 198 participants.

Also called NCT01837069

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 198 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01837069
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01837069. Randomized; no masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2018-04-02 (actual). Results posted on 2020-07-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Risk Factor Control Before Orthopedic Surgery
Acronym
OPTMIZE-OS
Condition
Osteoarthritis
Condition
Cardiovascular Disease
Intervention (Drug)
Metoprolol
Intervention (Drug)
Lisinopril
Intervention (Drug)
Atorvastatin
Intervention (Behavioral)
Lifestyle counseling
Lead sponsor
NYU Langone Health (class: other)

Record details

Record id
cardio:ct-nct01837069
Content hash
b094ca78752badcbea9b4ae88cca40e501275d0df457287f6f6d8de22ed3c7bf